Granulomatosis with polyangiitis

Known as: granulomatosis wegener's, WEGENERS GRANULOMATOSIS, with Polyangiitides, Granulomatosis 
A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in… (More)
National Institutes of Health

Related topics

Related topics

22 relations
ArteritisCardiovascular systemChurg-Strauss SyndromeCyclophosphamide
(More)

Broader (4)

Collagen DiseasesPolyarteritis Nodosaautoimmune vasculitisgranulomatous inflammation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
OBJECTIVE First, to investigate the overall efficacy and safety of rituximab (RTX) in refractory granulomatosis with polyangiitis… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
OBJECTIVE This study was conducted to evaluate the efficacy and safety of repeated and prolonged B cell depletion with rituximab… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Etanercept plus standard therapy for Wegener's granulomatosis.
BACKGROUND The majority of patients with Wegener's granulomatosis have disease flares after conventional medications are tapered… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity.
The American Cancer Society (ACS) publishes Nutrition and Physical Activity Guidelines to serve as a foundation for its… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.
Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) are both frequently associated with antineutrophil cytoplasmic… (More)
Is this relevant?
Review
1994
Review
1994
Nomenclature of systemic vasculitides. Proposal of an international consensus conference.
The following are some of the conclusions and proposals made at the Chapel Hill Consensus Conference on the Nomenclature of… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Wegener granulomatosis: an analysis of 158 patients.
OBJECTIVE To prospectively study the clinical features, pathophysiology, treatment and prognosis of Wegener granulomatosis… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.
Criteria for the classification of Wegener's granulomatosis (WG) were developed by comparing 85 patients who had this disease… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS
Immunoglobulin G (IgG) autoantibodies against extranuclear components of polymorphonuclear granulocytes were detected in 25 of 27… (More)
Is this relevant?
Review
1983
Review
1983
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.
Eighty-five patients with Wegener's granulomatosis were studied for 21 years at the National Institutes of Health. Patients were… (More)
Is this relevant?